Aardvark Therapeutics, Inc. Gains 52%
Fri, Jul 10, 2026 at 07:42 PM
Aardvark Therapeutics, Inc. (AARD:NASDAQ) shot up at $7.6, representing a gain of 52%. On Fri, Jul 10, 2026, AARD:NASDAQ hit a New 2-Week High of $7.6. The stock appeared on our News Catalysts scanner on Thu, Jun 25, 2026 at 10:23 AM in the 'BIOTECH' category. From Fri, Jun 26, 2026, the stock recorded 55.56% Up Days and 50.00% Green Days
About Aardvark Therapeutics, Inc. (AARD:NASDAQ)
Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic...
Top 10 Gainers:
- Global Mofy AI Limited (GMM:NASDAQ), 147.03%
- Jiuzi Holdings, Inc. (JZXN:NASDAQ), 85.47%
- Nuvve Holding Corp. (NVVE:NASDAQ), 55.69%
- Aardvark Therapeutics, Inc. (AARD:NASDAQ), 52%
- SUNation Energy Inc. (SUNE:NASDAQ), 49.61%
- Zhibao Technology Inc. (ZBAO:NASDAQ), 43.18%
- J-Star Holding Co. Ltd. (YMAT:NASDAQ), 28.42%
- Snail, Inc. (SNAL:NASDAQ), 26.67%
- Polibeli Group Ltd (PLBL:NASDAQ), 26.48%
- Ming Shing Group Holdings Limited (PMA:NASDAQ), 25.58%